Cargando…
371 Decreased Contraction Rate, Altered Calcium Transients, and Increased Proliferation seen in Patient-specific iPSC-CMs Modeling Ebsteins Anomaly and Left Ventricular Noncompaction
OBJECTIVES/GOALS: In a familial case where 10 of 17 members inherited EA/LVNC in an autosomal dominant pattern, we discovered a novel, damaging missense variant in the gene KLHL26 that segregates with disease and comprises an altered electrostatic surface profile, likely decoupling the CUL3-interact...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209070/ http://dx.doi.org/10.1017/cts.2022.211 |
_version_ | 1784729857724252160 |
---|---|
author | Samudrala, Sai Suma Anfinson, Melissa Cavanaugh, Matthew Kim, Min-Su Lamberton, Peter Radandt, Jackson Brown, Ryan Liang, Huan Ling Stamm, Karl Zeeshan, Afzal Strande, Jennifer Frommelt, Michele Lough, John W. Fitts, Robert Mitchell, Michael E. Tomita-Mitchel, Aoy |
author_facet | Samudrala, Sai Suma Anfinson, Melissa Cavanaugh, Matthew Kim, Min-Su Lamberton, Peter Radandt, Jackson Brown, Ryan Liang, Huan Ling Stamm, Karl Zeeshan, Afzal Strande, Jennifer Frommelt, Michele Lough, John W. Fitts, Robert Mitchell, Michael E. Tomita-Mitchel, Aoy |
author_sort | Samudrala, Sai Suma |
collection | PubMed |
description | OBJECTIVES/GOALS: In a familial case where 10 of 17 members inherited EA/LVNC in an autosomal dominant pattern, we discovered a novel, damaging missense variant in the gene KLHL26 that segregates with disease and comprises an altered electrostatic surface profile, likely decoupling the CUL3-interactome. We hypothesize that this KLHL26 variant is etiologic of EA/LVNC. METHODS/STUDY POPULATION: We differentiated a family trio (a heart-healthy daughter and EA/LVNC-affected mother and daughter) of induced pluripotent stem cells into cardiomyocytes (iPSC-CMs) in a blinded manner on three iPSC clones per subject. Using flow cytometry, immunofluorescence, and biomechanical, electrophysiological, and automated contraction methods, we investigated iPSC-CM differentiation efficiency between D10-20, contractility analysis and cell cycle regulation at D20, and sarcomere organization at D60. We further conducted differential analyses following label-free protein and RNA-Seq quantification at D20. Via CRISPR-Cas9 gene editing, we plan to characterize KLHL26 variant-specific iPSC-CM alterations and connect findings to discoveries from patient-specific studies. RESULTS/ANTICIPATED RESULTS: All iPSC lines differentiated into CMs with an increased percentage of cTnT+ cells in the affected daughter line. In comparison to the unaffected, affected iPSC-CMs had fewer contractions per minute and altered calcium transients, mainly a higher amount of total calcium release, faster rate of rise and faster rate of fall. The affected daughter line further had shorter shortening and relaxation times, higher proliferation, lower apoptosis, and a smaller cell surface area per cardiac nucleus. The affected mother line trended in a similar direction to the affected daughter line. There were no gross differences in sarcomere organization between the lines. We also discovered differential expression of candidate proteins such as kinase VRK1 and collagen COL5A1 from proteomic profiling. DISCUSSION/SIGNIFICANCE: These discoveries suggest that EA/LVNC characteristics or pathogenesis may result from decreased contractile ability, altered calcium transients, and cell cycle dysregulation. Through the KLHL26 variant correction and introduction in the daughter lines, we will build upon this understanding to inform exploration of critical clinical targets. |
format | Online Article Text |
id | pubmed-9209070 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-92090702022-07-01 371 Decreased Contraction Rate, Altered Calcium Transients, and Increased Proliferation seen in Patient-specific iPSC-CMs Modeling Ebsteins Anomaly and Left Ventricular Noncompaction Samudrala, Sai Suma Anfinson, Melissa Cavanaugh, Matthew Kim, Min-Su Lamberton, Peter Radandt, Jackson Brown, Ryan Liang, Huan Ling Stamm, Karl Zeeshan, Afzal Strande, Jennifer Frommelt, Michele Lough, John W. Fitts, Robert Mitchell, Michael E. Tomita-Mitchel, Aoy J Clin Transl Sci Valued Approaches OBJECTIVES/GOALS: In a familial case where 10 of 17 members inherited EA/LVNC in an autosomal dominant pattern, we discovered a novel, damaging missense variant in the gene KLHL26 that segregates with disease and comprises an altered electrostatic surface profile, likely decoupling the CUL3-interactome. We hypothesize that this KLHL26 variant is etiologic of EA/LVNC. METHODS/STUDY POPULATION: We differentiated a family trio (a heart-healthy daughter and EA/LVNC-affected mother and daughter) of induced pluripotent stem cells into cardiomyocytes (iPSC-CMs) in a blinded manner on three iPSC clones per subject. Using flow cytometry, immunofluorescence, and biomechanical, electrophysiological, and automated contraction methods, we investigated iPSC-CM differentiation efficiency between D10-20, contractility analysis and cell cycle regulation at D20, and sarcomere organization at D60. We further conducted differential analyses following label-free protein and RNA-Seq quantification at D20. Via CRISPR-Cas9 gene editing, we plan to characterize KLHL26 variant-specific iPSC-CM alterations and connect findings to discoveries from patient-specific studies. RESULTS/ANTICIPATED RESULTS: All iPSC lines differentiated into CMs with an increased percentage of cTnT+ cells in the affected daughter line. In comparison to the unaffected, affected iPSC-CMs had fewer contractions per minute and altered calcium transients, mainly a higher amount of total calcium release, faster rate of rise and faster rate of fall. The affected daughter line further had shorter shortening and relaxation times, higher proliferation, lower apoptosis, and a smaller cell surface area per cardiac nucleus. The affected mother line trended in a similar direction to the affected daughter line. There were no gross differences in sarcomere organization between the lines. We also discovered differential expression of candidate proteins such as kinase VRK1 and collagen COL5A1 from proteomic profiling. DISCUSSION/SIGNIFICANCE: These discoveries suggest that EA/LVNC characteristics or pathogenesis may result from decreased contractile ability, altered calcium transients, and cell cycle dysregulation. Through the KLHL26 variant correction and introduction in the daughter lines, we will build upon this understanding to inform exploration of critical clinical targets. Cambridge University Press 2022-04-19 /pmc/articles/PMC9209070/ http://dx.doi.org/10.1017/cts.2022.211 Text en © The Association for Clinical and Translational Science 2022 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work. |
spellingShingle | Valued Approaches Samudrala, Sai Suma Anfinson, Melissa Cavanaugh, Matthew Kim, Min-Su Lamberton, Peter Radandt, Jackson Brown, Ryan Liang, Huan Ling Stamm, Karl Zeeshan, Afzal Strande, Jennifer Frommelt, Michele Lough, John W. Fitts, Robert Mitchell, Michael E. Tomita-Mitchel, Aoy 371 Decreased Contraction Rate, Altered Calcium Transients, and Increased Proliferation seen in Patient-specific iPSC-CMs Modeling Ebsteins Anomaly and Left Ventricular Noncompaction |
title | 371 Decreased Contraction Rate, Altered Calcium Transients, and Increased Proliferation seen in Patient-specific iPSC-CMs Modeling Ebsteins Anomaly and Left Ventricular Noncompaction |
title_full | 371 Decreased Contraction Rate, Altered Calcium Transients, and Increased Proliferation seen in Patient-specific iPSC-CMs Modeling Ebsteins Anomaly and Left Ventricular Noncompaction |
title_fullStr | 371 Decreased Contraction Rate, Altered Calcium Transients, and Increased Proliferation seen in Patient-specific iPSC-CMs Modeling Ebsteins Anomaly and Left Ventricular Noncompaction |
title_full_unstemmed | 371 Decreased Contraction Rate, Altered Calcium Transients, and Increased Proliferation seen in Patient-specific iPSC-CMs Modeling Ebsteins Anomaly and Left Ventricular Noncompaction |
title_short | 371 Decreased Contraction Rate, Altered Calcium Transients, and Increased Proliferation seen in Patient-specific iPSC-CMs Modeling Ebsteins Anomaly and Left Ventricular Noncompaction |
title_sort | 371 decreased contraction rate, altered calcium transients, and increased proliferation seen in patient-specific ipsc-cms modeling ebsteins anomaly and left ventricular noncompaction |
topic | Valued Approaches |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209070/ http://dx.doi.org/10.1017/cts.2022.211 |
work_keys_str_mv | AT samudralasaisuma 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT anfinsonmelissa 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT cavanaughmatthew 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT kimminsu 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT lambertonpeter 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT radandtjackson 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT brownryan 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT lianghuanling 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT stammkarl 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT zeeshanafzal 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT strandejennifer 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT frommeltmichele 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT loughjohnw 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT fittsrobert 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT mitchellmichaele 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction AT tomitamitchelaoy 371decreasedcontractionratealteredcalciumtransientsandincreasedproliferationseeninpatientspecificipsccmsmodelingebsteinsanomalyandleftventricularnoncompaction |